| 注册
首页|期刊导航|中国药房|基于组学技术的中医药干预腹泻型肠易激综合征机制研究进展

基于组学技术的中医药干预腹泻型肠易激综合征机制研究进展

高山雪 马佳乐 彭龙 陈婕

中国药房2026,Vol.37Issue(3):401-406,6.
中国药房2026,Vol.37Issue(3):401-406,6.DOI:10.6039/j.issn.1001-0408.2026.03.22

基于组学技术的中医药干预腹泻型肠易激综合征机制研究进展

Progress in mechanistic research on traditional Chinese medicine interventions for irritable bowel syndrome with diarrhea based on omics technologies

高山雪 1马佳乐 2彭龙 2陈婕2

作者信息

  • 1. 天津中医药大学研究生院,天津 301617
  • 2. 天津中医药大学第二附属医院消化科,天津 300250
  • 折叠

摘要

Abstract

Irritable bowel syndrome with diarrhea(IBS-D),as a prototypical disorder involving the microbiota-gut-brain axis,remains poorly understood in terms of its pathogenesis,posing ongoing challenges for clinical diagnosis.Omics technologies,leveraging their high-throughput detection and systematic analysis advantages,has emerged as a critical tool for deciphering the complex mechanisms underlying traditional Chinese medicine(TCM)treatment of IBS-D.This systematic review summarizes the research progress of transcriptomics,proteomics,metabolomics,microbiomics,and multi-omics integration techniques in TCM interventions for IBS-D.In single-omics studies,transcriptomics using techniques like RNA-seq,reveals the regulatory mechanisms of TCM on IBS-related signaling pathways.Proteomics,leveraging quantitative technologies such as 2D-difference gel electrophoresis and tandem mass tag,identifies differentially expressed proteins and elucidates the action targets of TCM in treating IBS-D.Metabolomics,employing methods like UPLC-Q-TOF-MS and LC-MS/MS,discovers metabolic pathways regulated by TCM to improve metabolic disturbances in IBS-D.Microbiomics,based on 16S rRNA sequencing,confirms that TCM can reshape the gut microbiota structure and restore the intestinal microecological balance,thereby improving IBS-D.Multi-omics integration further overcomes the limitations of single-omics approaches by synthesizing information from transcriptomics,proteomics,metabolomics,and microbiomics,enabling a more comprehensive and systematic elucidation of the complex mechanisms underlying TCM treatment for IBS-D.In the future,research related to IBS-D should be advanced from three aspects:stratified clinical research based on TCM syndrome types,multi-omics integration verification mechanisms,and emerging omics to explore new mechanisms,providing more innovative ideas for the precise diagnosis and treatment of this disease.

关键词

肠易激综合征/中医药/肠道微生态/转录组学/蛋白质组学/代谢组学/微生物组学/多组学整合

Key words

irritable bowel syndrome/traditional Chinese medicine/gut microbiota/transcriptomics/proteomics/metabolomics/microbiomics/multi-omics integration

分类

医药卫生

引用本文复制引用

高山雪,马佳乐,彭龙,陈婕..基于组学技术的中医药干预腹泻型肠易激综合征机制研究进展[J].中国药房,2026,37(3):401-406,6.

基金项目

天津市教委科研计划项目(No.2024ZD012,No.2021KJ152) (No.2024ZD012,No.2021KJ152)

中国药房

1001-0408

访问量0
|
下载量0
段落导航相关论文